海洋化合物在人类内皮原生细胞中表现出抗衰老作用,通过增加Sirtuin1表达
Jing Yang1, Jie Li2, Ting-Ting Wei1
1Department of Pharmacology, Cardiac & Cerebral Vascular Research Center, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China.
ACS pharmacology & translational science
|November 17, 2023
概括
化合物3 (C3) 通过增强1型Sirtuin (SIRT1) 和平衡AMPK/Akt通路,防止人类内皮前体细胞 (hEPC) 的衰老. 这种海洋化合物显示出治疗与年龄有关的心血管疾病的潜力.
科学领域:
- 心血管疾病研究研究
- 细胞衰老机制 细胞衰老机制
- 海洋天然产品 海洋天然产品
背景情况:
- 老龄化增加了心血管疾病的风险.
- 内皮原生细胞 (hEPC) 对于血管健康至关重要.
- 海洋衍生化合物正在探索其治疗潜力.
研究的目的:
- 为了研究化合物3 (C3) 对人类内皮原生细胞 (hEPC) 衰老的影响.
- 阐明C3对与年龄有关的内皮功能障碍的保护作用背后的分子机制.
主要方法:
- 使用血管新生素II (AngII) 诱导 hEPC衰老.
- 对衰老标志物的评估 (SA-β-银酸酶,端粒酶活性,活力).
- 对关键信号通路 (SIRT1,AMPK,Akt) 的分析和对特定抑制剂的干预.
主要成果:
- AngII诱导了HEPC衰老,减少了端粒酶活性和活力.
- 取决于C3的剂量,逆转了AngII诱导的衰老,并恢复了细胞功能.
- C3增加了SIRT1表达和调节AMPK/Akt酸化,影响取决于SIRT1活动.
结论:
- 化合物3通过SIRT1上调和AMPK/Akt通路调节来保护HEPCs免受AngII诱导的衰老.
- C3显示出作为治疗老化相关心血管疾病的治疗剂的潜力.
- 用C3准HEPC衰老可能会减轻老年人内皮功能障碍.
更多相关视频
11:35Decellularization and Recellularization Methodology for Human Saphenous Veins
Published on: July 27, 2018
14.3K
08:43Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
Published on: February 14, 2017
11.0K
相关概念视频
Mitochondria
13.4K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.4K
Electron Transport Chain: Complex I and II
14.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.1K
